시장보고서
상품코드
1182892

세계의 T 세포 치료 시장(2022-2028년) : COVID-19의 영향 분석, 모달리티별, 치료 종류별, 적응증별, 지역별 - 업계 분석, 시장 규모, 시장 점유율, 예측

T-cell Therapy Market with COVID-19 Impact Analysis, By Modality, By Therapy Type, By Indication, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 366 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 T 세포 치료 시장 규모는 2021년에 53억 70만 달러에 달하고, 2022-2028년 예측기간 중 23.9%의 CAGR로 확대될 것으로 예상됩니다.

세계의 T 세포 치료(T-cell Therapy) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인·억제요인 분석, 시장 기회, COVID-19의 영향, 부문별 시장 분석, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공하고 있습니다.

목차

제1장 T 세포 치료 시장 : 개요

제2장 주요 요약

  • 시장 내역
    • 모달리티별
    • 치료 종류별
    • 적응증별
    • 국가별
    • 지역별
  • 경쟁 분석

제3장 T 세포 치료 시장 : 주요 동향

  • 시장 성장 촉진요인
    • 시장 성장 촉진요인의 영향 분석
  • 시장 성장 억제요인
    • 시장 성장 억제요인의 영향 분석
  • 시장 기회
  • 시장 향후 동향

제4장 T 세포 치료 : 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 T 세포 치료 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 T 세포 치료 시장 : 상황

  • 시장 점유율 분석(2021년)
  • 주요 제조업체별 내역 데이터
    • 확립된 기업 분석
    • 신흥 기업 분석

제7장 T 세포 치료 시장 : 모달리티별

  • 개요

제8장 T 세포 치료 시장 : 치료 종류별

  • 개요

제9장 T 세포 치료 시장 : 적응증별

  • 개요

제10장 T 세포 치료 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제11장 T 세포 치료 업계 : 주요 벤더 분석

  • 경쟁 대시보드
  • 기업 개요
    • Pfizer Inc.
    • Bluebird Bio Inc.
    • Gilead Sciences Inc.
    • TCR2 Therapeutics Inc
    • Merck KGaA
    • Sorrento Therapeutics
    • Fate Therapeutics
    • Novartis AG
    • Amgen
    • Celgene Corporation
    • CASI Pharmaceuticals
    • Poseida Therapeutics

제12장 애널리스트의 종합적 전망

제13장 부록

KSM 23.01.25

REPORT HIGHLIGHT

The T-cell Therapy Market size was valued at USD 5,300.7 Million in 2021, expanding at a CAGR of 23.9% from 2022 to 2028.

T-cell therapy is an immunotherapy technique known as adoptive cell transfer (ACT), in which immune cells from the patient's body are used to treat cancer. T-cells are collected via apheresis and re-engineered in a laboratory. These re-engineered cells are then reproduced and injected into the body, where they recognize and kill cancer cells with specific antigens on their surface.

Market Dynamics

Tobacco use is on the rise, as are bad eating habits and sedentary lifestyles, which are all contributing to an increase in cancer risk. This, together with the growing number of people diagnosed with bone marrow and blood-forming tissue diseases, is one of the key causes driving the demand for T-cell therapy. Furthermore, the widespread coronavirus disease (COVID-19) has spurred researchers around the world to use T-cell treatments to treat high-risk individuals. Aside from that, increased consumer awareness of medical services, combined with favorable government policies and regulations, is boosting market expansion. Furthermore, the US Food and Drug Administration (USFDA) has approved T-cell treatments for the treatment of children with acute lymphoblastic leukemia (ALL) and adults with advanced lymphomas. This is expected to generate attractive prospects for producers and stimulate market expansion.

Segmentation Analysis:

The Global T-cell Therapy Market is segmented based on Modality, Therapy Type, Indication, and Region.

Based on modality, the market is divided into Research and Commercialized. The research segment is expected to dominate the market during the forecast period. The growth in the segment is attributed to a large number of products in the clinical development stage. A significant number of research institutes, such as the Mayo Clinic, are actively involved in CAR-T therapy projects, hence endorsing the procedure as a preferred method of cancer management. Several operational organizations are engaging with research communities all around the world, which has resulted in a shift in emphasis toward speeding the development of CAR-T therapies to broaden the therapeutic application landscape. Immune Therapeutics, for example, cooperated with Institut d'Investigacions Biomediques August Pi I Sunyer and Hospital Clinic de Barcelona in October 2020 for the research and marketing of CAR-T therapy in India. Thus, driving segmental growth.

Regionally, North America is expected to dominate the market during the forecast period. The region's market growth is primarily ascribed to considerable research and a commercial base for cancer immunotherapy, as well as a large number of clinical trials for T-cell treatments in the United States. Furthermore, the increasing number of regulatory approvals for T-cell treatments in the United States and Canada, as well as the shifting reimbursement scenario in the region, has fueled the market expansion. The existence of a large number of medical facilities delivering CAR-T cell therapies further adds to the growth of the regional market.

Recent Development:

In January 2021, ImmunoPAC-T-CB T cells were introduced by OrganaBio. These cells are derived from full-term umbilical cord blood donated by donors who support the development of allogeneic immune cell-based therapies.

In July 2020, Kite's newly introduced medication, Tecartus, has been approved by the US Food and Drug Administration. It is a CAR T-cell therapy intended for adult patients with relapsed or refractory mantle cell lymphoma (MCL).

Key features of the study:

  • This proposed research study on the T-cell Therapy market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
  • The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the T-cell Therapy market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the T-cell Therapy market
  • The impact of COVID-19 on the T-cell Therapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the T-cell Therapy market post-COVID will also be covered.
  • To give the users of this report a comprehensive view of the T-cell Therapy market, we have also included a competitive landscape and key innovator analysis for the T-cell Therapy market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the T-cell Therapy market.
  • In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
  • The global T-cell Therapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL T-CELL THERAPY MARKET KEY PLAYERS

  • Pfizer Inc.
  • Bluebird Bio Inc.
  • Gilead Sciences Inc.
  • TCR2 Therapeutics Inc
  • Merck KGaA
  • Sorrento Therapeutics
  • Fate Therapeutics
  • Novartis AG
  • Amgen
  • Celgene Corporation
  • CASI Pharmaceuticals
  • Poseida Therapeutics

GLOBAL T-CELL THERAPY MARKET, BY MODALITY

  • Research
  • Commercialized

GLOBAL T-CELL THERAPY MARKET, BY THERAPY TYPE

  • CAR T-cell Therapy
  • T Cell Receptor (TCR)-based
  • Tumor Infiltrating Lymphocytes (TIL)-based

GLOBAL T-CELL THERAPY MARKET, BY INDICATION

  • Hematologic Malignancies
  • Solid Tumors
  • Others

GLOBAL T-CELL THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

TABLE OF CONTENT

1. T-cell Therapy Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. T-cell Therapy Market Snippet by Modality
    • 2.1.2. T-cell Therapy Market Snippet by Therapy Type
    • 2.1.3. T-cell Therapy Market Snippet by Indication
    • 2.1.4. T-cell Therapy Market Snippet by Country
    • 2.1.5. T-cell Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. T-cell Therapy Key Market Trends

  • 3.1. T-cell Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. T-cell Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. T-cell Therapy Market Opportunities
  • 3.4. T-cell Therapy Market Future Trends

4. T-cell Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. T-cell Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. T-cell Therapy Market Landscape

  • 6.1. T-cell Therapy Market Share Analysis, 2021
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. T-cell Therapy Market - By Modality

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Modality, 2021 & 2028 (%)
    • 7.1.2. Research
    • 7.1.3. Commercialized

8. T-cell Therapy Market - By Therapy Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy Type, 2021 & 2028 (%)
    • 8.1.2. CAR T-cell Therapy
    • 8.1.3. T Cell Receptor (TCR)-based
    • 8.1.4. Tumor Infiltrating Lymphocytes (TIL)-based

9. T-cell Therapy Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2021 & 2028 (%)
    • 9.1.2. Hematologic Malignancies
    • 9.1.3. Solid Tumors
    • 9.1.4. Others

10. T-cell Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. T-cell Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. T-cell Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. T-cell Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. T-cell Therapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. T-cell Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Modality, 2017 - 2028 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2017 - 2028 (US$ Million)

11. Key Vendor Analysis- T-cell Therapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Bluebird Bio Inc.
    • 11.2.3. Gilead Sciences Inc.
    • 11.2.4. TCR2 Therapeutics Inc
    • 11.2.5. Merck KGaA
    • 11.2.6. Sorrento Therapeutics
    • 11.2.7. Fate Therapeutics
    • 11.2.8. Novartis AG
    • 11.2.9. Amgen
    • 11.2.10. Celgene Corporation
    • 11.2.11. CASI Pharmaceuticals
    • 11.2.12. Poseida Therapeutics

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제